Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Tejaswi KandulaSusanna B Park

Abstract

Chemotherapy induced peripheral neuropathy (CIPN) is a significant toxicity of cancer treatment, with the potential to affect long-term function and quality of life in cancer survivors. There remains a lack of consensus around optimal assessment techniques. While current approaches to CIPN assessment are focused on clinical grading scales, it is becoming increasingly evident that a more comprehensive multimodal assessment package is necessary to accurately characterise the impact of CIPN as well as gauge the utility of neuroprotective mechanisms. Neurophysiological techniques provide objective biomarkers and may enable early detection of toxicity while patient reported outcomes are necessary to determine the significance of symptoms to individual patients. In addition to providing an objective assessment, clinical neurophysiological techniques provide important insights into the contributory pathophysiological mechanisms of CIPN with different chemotherapy agents. There is a paucity of implementation of these techniques in the clinical trial setting. The present Review aims to facilitate the use of neurophysiological studies as part of comprehensive assessment packages for the monitoring of CIPN by summarising current understan...Continue Reading

Associated Clinical Trials

Citations

Jul 26, 2019·Neurorehabilitation and Neural Repair·Elizabeth Andersen HammondBarbara Shay
Nov 25, 2018·The Oncologist·Lara Sánchez-BarrosoCristina Rodríguez-Antona
Mar 7, 2020·The Journal of Clinical Investigation·Manchao ZhangFen Xia
Jan 12, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Hannah C TimminsSusanna B Park
Oct 28, 2019·Journal of the Peripheral Nervous System : JPNS·Stefano TamburinAndreas A Argyriou
Sep 10, 2020·Journal of the Peripheral Nervous System : JPNS·Kristine BennedsgaardNanna B Finnerup
Feb 13, 2021·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Tina L DoshiSrinivasa N Raja
Jan 22, 2020·Seminars in Oncology Nursing·Robert KnoerlEllen M Lavoie Smith
Mar 7, 2021·International Journal of Molecular Sciences·Scarlett Acklin, Fen Xia
Mar 7, 2021·International Journal of Molecular Sciences·Mariarita LaforgiaGirolamo Ranieri
Apr 15, 2021·Journal of Neuroinflammation·Xuelin HuangXiangcai Ruan
Dec 5, 2020·Pharmacology & Therapeutics·Ibrahim Y AbdelgawadBeshay N Zordoky
Jun 19, 2021·The Ocular Surface·Jeremy Chung Bo ChiangMaria Markoulli
Oct 17, 2021·Oncology and Therapy·Jamie BurgessUazman Alam
Dec 5, 2019·Breast Care·Berit JordanKarin Jordan

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Related Papers

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Floortje MolsLonneke van de Poll-Franse
Progress in Molecular Biology and Translational Science
Jill C Fehrenbacher
Annals of Oncology : Official Journal of the European Society for Medical Oncology
T J Postma, J J Heimans
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Jennifer Piccolo, Jill M Kolesar
© 2022 Meta ULC. All rights reserved